Outcomes after dose escalation of infliximab in Japanese patients with Crohn's disease

被引：0
|
作者：
Sako, M. [1 ]
Kawaguchi, T. [1 ]
Hirayama, A. [1 ]
Fukushi, G. [1 ]
Hayama, K. [1 ]
Fujiwara, T. [1 ]
Yoshimura, N. [1 ]
Takazoe, M. [1 ]
机构：
[1] Social Insurance Cent Hosp, Ctr Inflammatory Bowel Dis, Tokyo, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60517-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P397
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [21] Efficacy, Safety, and Pharmacokinetics of Infliximab Dose Escalation in Pediatric Patients With Crohn's Disease or Ulcerative Colitis: An Analysis of the DEVELOP Registry
    Dubinsky, Marla C.
    Markowitz, James
    Busse, Christopher
    Koletzko, Sibylle
    Winter, Harland
    Baldassano, Robert
    Colletti, Richard
    Kugathasan, Subra
    Ruemmele, Frank
    Griffiths, Anne
    Gasink, Christopher
    Adedokun, Omoniyi
    Izanec, James L.
    Gao, Long-Long
    Ma, Tony
    Ott, Elyssa
    Hyams, Jeffrey
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S592 - S593
  • [22] Previous Non-Response to Infliximab Predicts Early Dose-Escalation in Adalimumab Treated Crohn's Disease Patients
    Bultman, Evelien
    West, Rachel L.
    van Liere-Baron, Astrid
    Kuipers, Ernst J.
    Zelinkova, Zuzana
    Woude, Janneke V.
    GASTROENTEROLOGY, 2010, 138 (05) : S701 - S702
  • [23] Long-Term Outcomes of Switching from Infliximab to Adalimumab for Japanese Patients with Crohn's Disease Whose Infliximab Treatment Failed
    Tanaka, Hiroki
    Sugiyama, Kohei
    Miyakawa, Maki
    Nasuno, Masanao
    Motoya, Satoshi
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S29 - S29
  • [24] THE EFFECT OF INFLIXIMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTIBODIES TO INFLIXIMAB
    Tun, Gloria S. Z.
    Marshall, Laura
    Thompson, Laura
    Campbell, Rebecca
    Hale, Melissa F.
    Chew, Thean S.
    Brooks, Alenka J.
    Robinson, Kerry
    Lobo, Alan J.
    GUT, 2019, 68 : A61 - A62
  • [25] The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab
    Tun, Gloria S. Z.
    Robinson, Kerry
    Marshall, Laura
    Wright, Alison
    Thompson, Laura
    Wild, Graeme
    Sargur, Ravishankar
    Brooks, Alenka J.
    Hale, Melissa F.
    Chew, Thean S.
    Lobo, Alan J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (03) : 295 - 301
  • [26] EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN CROHN'S DISEASE
    Ollech, Jacob
    Normatov, Inessa
    Peleg, Noam
    Patel, Shivani
    Rai, Victoria
    Wang, Jingzhou D.
    Yi, Yangtian
    Singer, Jorie
    Dalal, Sushila
    Sakuraba, Atsushi
    Cohen, Russell D.
    Rubin, David T.
    Pekow, Joel R.
    GASTROENTEROLOGY, 2020, 158 (06) : S961 - S961
  • [27] OUTCOMES OF ACCELERATED VS. STANDARD INFLIXIMAB INDUCTION DOSE IN CROHN'S DISEASE
    Almomen, Hisham S.
    Sayed, Amr
    Chipkin, Benjamin
    Nawaz, Ahmad
    Gaidos, Jill K.
    Proctor, Deborah D.
    Al Bawardy, Badr
    GASTROENTEROLOGY, 2023, 164 (06) : S1132 - S1132
  • [28] Durability of Infliximab Dose Intensification in Crohn’s Disease
    Kirk K. Lin
    Fernando Velayos
    Elena Fisher
    Jonathan P. Terdiman
    Digestive Diseases and Sciences, 2012, 57 : 1013 - 1019
  • [29] Evidence of infliximab dose stability in Crohn's disease
    Cohen, R
    Farr, C
    Ziskind, M
    Tandon, N
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S228 - S228
  • [30] Durability of Infliximab Dose Intensification in Crohn's Disease
    Lin, Kirk K.
    Velayos, Fernando
    Fisher, Elena
    Terdiman, Jonathan P.
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) : 1013 - 1019
12345